VR
Vivek Rathi
About Vivek Rathi
Data last updated:
Vivek Rathi was a Director at Thermo Fisher Scientific India Private Limited (2013–2016), Director at American Express Foreign Exchange Servic Es India Limited (2009–2013) and Director at American Express(India) Private Limited (2010–2013), and held 3 more directorships. The companies operate in Healthcare, Transportation and Financial Services.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Feb 2013 | 2000 | ₹2,554 Cr (FY 2025) | Active | |
| Director | 19 Mar 2009 | 1984 | Amalgamated | ||
| Director | 01 Oct 2010 | 1994 | ₹9,976 Cr (FY 2025) | Active | |
| Additional Director | 06 Feb 2013 | 2008 | Amalgamated | ||
| Additional Director | 06 Feb 2013 | 1997 | Amalgamated | ||
| Director | 02 Feb 2009 | 2007 | Dissolved (Liquidated) |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Rathi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Rathi
Vivek Rathi was first appointed on 02 Feb 2009 as Director at American Express International (India) Private Limited. The most recent appointment on record is 06 Feb 2013 at Kendro Laboratory Products India Private Limited.
Vivek Rathi held 6 earlier board appointments: Thermo Fisher Scientific India Private Limited (Director, 06 Feb 2013 to 05 Oct 2016); American Express Foreign Exchange Servic Es India Limited (Director, 19 Mar 2009 to 28 Jan 2013); American Express(India) Private Limited (Director, 01 Oct 2010 to 28 Jan 2013); Tka India Private Limited (Additional Director, from 06 Feb 2013); Kendro Laboratory Products India Private Limited (Additional Director, from 06 Feb 2013); and 1 more.